Metoprolol Export Market Intelligence: India's 306 Suppliers Shipping to 118 Countries — TransData Nexus 2026

Q: Who are the top metoprolol exporters from India?

The top metoprolol exporters from India are: 1. RUBICON RESEARCH PRIVATE LIMITED — $272.7M (33.6% market share); 2. CIPLA LIMITED — $224.7M (27.7% market share); 3. ALKEM LABORATORIES LIMITED — $94.7M (11.7% market share); 4. MYLAN LABORATORIES LIMITED — $63.4M (7.8% market share); 5. DR.REDDY'S LABORATORIES LTD — $61.4M (7.6% market share). Together they account for 88.4% of India's total metoprolol export value.

Q: What is the total export value of metoprolol from India?

The total export value of metoprolol from India is $811.1M USD, recorded across 10,118 shipment transactions from 306 active exporters to 118 destination countries. The average shipment value is $80.2K.

Q: Which countries import metoprolol from India?

India exports metoprolol to 118 countries worldwide. The top importing countries are: UNITED STATES (94.0% share, $762.1M), BRAZIL (4.6% share, $37.2M), MYANMAR (0.3% share, $2.8M), AUSTRALIA (0.3% share, $2.1M), PHILIPPINES (0.1% share, $835.2K). These five markets account for 99.3% of total export value.

Q: What is the HS code for metoprolol exports from India?

The primary HS code for metoprolol exports from India is 30049074. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of metoprolol exports from India?

The average unit price for metoprolol exports from India is $2.53 USD per unit, with prices ranging from $0.00 to $1641.10 depending on formulation, packaging, and order volume. The total market is valued at $811.1M across 10,118 shipments.

Q: Which ports handle metoprolol exports from India?

The primary ports for metoprolol exports from India are SAHAR AIR (16.2% of shipments), SAHAR AIR CARGO ACC (INBOM4) (10.8% of shipments), DELHI AIR CARGO ACC (INDEL4) (9.2% of shipments), HYDERABAD ICD (8.4% of shipments), DELHI AIR (6.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of metoprolol?

India is one of the world's leading exporters of metoprolol due to its large base of 306 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports metoprolol to 118 countries, demonstrating 61% global market coverage.

Q: What certifications do Indian metoprolol exporters need?

Indian metoprolol exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import metoprolol from India?

There are 949 registered buyers importing metoprolol from India, spread across 118 countries. The repeat buyer rate is 57.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top metoprolol supplier from India?

RUBICON RESEARCH PRIVATE LIMITED is the leading metoprolol exporter from India with a market share of 33.6% and total export value of $272.7M across 532 shipments. The top 5 suppliers together control 88.4% of total export value.

Suresh Sormare

Metoprolol

India Pharmaceutical Trade Intelligence

$811.1M306 Suppliers118 CountriesHS 30049074

ExportsIndia → UNITED STATES94.0%India → BRAZIL4.6%

ImportsSWEDEN → India$4565.7B UNITED STATES → India$1.3B

#1 Supplier: RUBICON RESEARCH #1 Buyer: CIPLA USA

Metoprolol Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Metoprolol to the World

Between 2022 and 2026, India exported $811.1M worth of metoprolol across 10,118 verified shipments to 118 countries — covering 61% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (94.0%). RUBICON RESEARCH PRIVATE LIMITED leads with a 33.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Metoprolol export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Metoprolol export data snapshot — $811.1M · 306 exporters · 118 countriesTransData Nexus · Indian Customs Data

Top Metoprolol Exporters from India

306 active exporters · Ranked by export value

View all 306 →

Top Metoprolol Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	RUBICON RESEARCH PRIVATE LIMITED	$272.7M	532	2	33.6%
2	CIPLA LIMITED

Top Countries Importing Metoprolol from India

118 destination markets · Ranked by import value

All 118 countries →

Top Countries Importing Metoprolol from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$762.1M	94.0%
2	BRAZIL	$37.2M	4.6%
3	MYANMAR	$2.8M	0.3%
4	AUSTRALIA	$2.1M	0.3%
5	PHILIPPINES	$835.2K	0.1%
6	GERMANY	$757.7K	0.1%
7	IRAQ	$651.9K	0.1%
8	BELARUS	$537.2K	0.1%
9	FRANCE	$379.7K	0.0%
10	CANADA	$255.9K	0.0%

UNITED STATES is India's largest metoprolol export destination, absorbing 94.0% of total exports worth $762.1M. The top 5 importing countries — UNITED STATES, BRAZIL, MYANMAR, AUSTRALIA, PHILIPPINES — together account for 99.3% of India's total metoprolol export value. The remaining 113 destination countries collectively receive the other 0.7%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Metoprolol to India?

14 origin countries · Total import value: $4567.0B

India imports metoprolol from 14 countries with a combined import value of $4567.0B. The largest supplier is SWEDEN ($4565.7B, 52 shipments), followed by UNITED STATES and CHINA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Metoprolol to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	SWEDEN	$4565.7B	52	100.0%
2	UNITED STATES	$1.3B	244	0.0%
3	CHINA	$253.0K	8	0.0%
4	GERMANY	$22.1K	42	0.0%
5	BRAZIL	$4.6K	20	0.0%
6	CANADA	$2.5K	68	0.0%
7	AUSTRIA	$1.9K	1	0.0%
8	UNITED KINGDOM	$1.8K	6	0.0%
9	SOMALIA	$1.7K	1	0.0%
10	NETHERLANDS	$1.4K	4	0.0%

Showing top 10 of 14 origin countries

SWEDEN is the largest supplier of metoprolol to India, accounting for 100.0% of total import value. The top 5 origin countries — SWEDEN, UNITED STATES, CHINA, GERMANY, BRAZIL — together supply 100.0% of India's metoprolol imports. Click any country to see detailed supplier and buyer data for that import corridor.

Metoprolol — Export Intelligence Video

Visual overview of India's metoprolol import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's metoprolol pharmaceutical import and export market — $811.1M in total trade, 306 verified manufacturers, and 118 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Metoprolol

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Metoprolol, a beta-blocker used primarily for cardiovascular conditions, has a significant presence in the U.S. pharmaceutical market. According to the FDA's Orange Book, numerous Abbreviated New Drug Applications (ANDAs) for metoprolol have been approved, indicating a robust generic market. Notably, in January 2026, the FDA approved an ANDA for metoprolol succinate extended-release tablets, further expanding the availability of this medication.

The substantial export of metoprolol from India to the United States underscores the importance of compliance with FDA regulations. With 306 active Indian exporters and 94% of exports directed to the U.S., adherence to FDA standards is paramount. The regulatory pathway for metoprolol involves demonstrating bioequivalence to the reference listed drug, ensuring consistent quality and efficacy. As of March 2026, there are no active FDA import alerts specifically targeting metoprolol from India, reflecting the industry's commitment to maintaining regulatory compliance.

2EU & UK Regulatory Framework

In the European Union, metoprolol is authorized through the decentralized procedure, allowing for simultaneous approval in multiple member states. The European Medicines Agency (EMA) oversees this process, ensuring that metoprolol meets stringent safety and efficacy standards. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates metoprolol, requiring compliance with the UK's specific regulatory requirements.

Manufacturers exporting metoprolol to these regions must adhere to Good Manufacturing Practice (GMP) guidelines as stipulated by the EMA and MHRA. These guidelines encompass quality management systems, personnel qualifications, and facility standards to ensure product quality and patient safety.

3WHO Essential Medicines & Global Standards

Metoprolol is listed in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, highlighting its critical role in treating cardiovascular diseases. This inclusion underscores the medication's importance in global health and its widespread acceptance.

Regarding pharmacopoeial standards, metoprolol is recognized in major compendia, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). These standards provide comprehensive guidelines on the drug's quality, purity, and strength, ensuring consistency across different markets.

4India Regulatory Classification

In India, metoprolol is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. This classification mandates that metoprolol can only be dispensed with a valid prescription from a registered medical practitioner.

The National Pharmaceutical Pricing Authority (NPPA) oversees the pricing of essential medicines in India. As of February 2026, the ceiling price for metoprolol has been set to ensure affordability and accessibility for patients. For exports, the Directorate General of Foreign Trade (DGFT) requires a No Objection Certificate (NOC) for certain pharmaceutical products. However, as of March 2026, metoprolol is not listed among the drugs requiring an export NOC, facilitating smoother international trade.

5Patent & Exclusivity Status

The primary patents for metoprolol have expired, leading to a competitive generic market. This expiration has allowed multiple manufacturers to produce and export metoprolol, contributing to its widespread availability and affordability.

6Recent Industry Developments

In May 2025, the NPPA revised the ceiling price for metoprolol, reducing it by 5% to enhance affordability for patients. This adjustment reflects the authority's commitment to making essential medicines more accessible.

In August 2025, the CDSCO issued new guidelines for the bioequivalence studies of metoprolol formulations, aiming to standardize testing procedures and ensure consistent product quality across manufacturers.

In November 2025, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of metoprolol in the 24th edition, published in September 2025. This reaffirms the drug's essential status in global healthcare.

In January 2026, the FDA approved a new generic version of metoprolol succinate extended-release tablets, increasing competition and potentially lowering prices in the U.S. market.

In February 2026, the EMA released updated GMP guidelines, emphasizing stricter controls for the manufacturing of beta-blockers, including metoprolol, to enhance product safety and efficacy.

These developments highlight the dynamic regulatory environment surrounding metoprolol, emphasizing the need for manufacturers and exporters to stay informed and compliant with evolving standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Metoprolol

Retail & reference prices across 9 markets vs. India FOB export price of $2.53/unit

Global Price Benchmark for Metoprolol across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.74	USD	According to the FDA's National Drug Code Directory, Metoprolol is available in various formulations, including 25 mg, 50 mg, 100 mg, and 200 mg tablets.
United Kingdom	N/A	GBP	Metoprolol is listed in the British National Formulary (BNF) with standard dosages of 25 mg, 50 mg, and 100 mg tablets.
Germany	N/A	EUR	Metoprolol is approved by the European Medicines Agency (EMA) and is available in standard dosages.
Australia	N/A

Supply Chain Risk Assessment — Metoprolol

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Metoprolol, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70-80% of India's API and KSM requirements are sourced from China, creating a significant dependency. This reliance exposes the supply chain to vulnerabilities, as any disruptions in Chinese manufacturing or export policies can directly affect the availability and cost of these essential materials.

Recent geopolitical tensions have further exacerbated this risk. For instance, in February 2026, the closure of the Strait of Hormuz due to military conflicts disrupted the supply of raw materials to Asia's petrochemical industry, leading to production cutbacks and force majeure declarations. Such events highlight the fragility of supply chains dependent on specific regions for critical inputs.

2Supplier Concentration & Single-Source Risk

The export market for Metoprolol from India is highly concentrated, with the top five exporters—Rubicon Research Private Limited, Cipla Limited, Alkem Laboratories Limited, Mylan Laboratories Limited, and Dr. Reddy's Laboratories Ltd—accounting for 88.4% of total exports. Rubicon Research alone holds a 33.6% share. This concentration poses a single-source risk; any operational or regulatory issues affecting these key players could significantly disrupt the supply chain.

Access Complete Metoprolol Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 10,118 transactions across 118 markets.

Request Demo View Pricing

Frequently Asked Questions — Metoprolol Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top metoprolol exporters from India?

The leading metoprolol exporters from India are RUBICON RESEARCH PRIVATE LIMITED, CIPLA LIMITED, ALKEM LABORATORIES LIMITED, and 12 others. RUBICON RESEARCH PRIVATE LIMITED leads with 33.6% market share ($272.7M). The top 5 suppliers together control 88.4% of total export value.

What is the total export value of metoprolol from India?

The total export value of metoprolol from India is $811.1M, recorded across 10,118 shipments from 306 active exporters to 118 countries. The average shipment value is $80.2K.

Which countries import metoprolol from India?

India exports metoprolol to 118 countries. The top importing countries are UNITED STATES (94.0%), BRAZIL (4.6%), MYANMAR (0.3%), AUSTRALIA (0.3%), PHILIPPINES (0.1%), which together account for 99.3% of total export value.

What is the HS code for metoprolol exports from India?

The primary HS code for metoprolol exports from India is 30049074. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Metoprolol

Metoprolol

Top Metoprolol Exporters from India

Top Countries Importing Metoprolol from India

Who Supplies Metoprolol to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Metoprolol — Export Intelligence Video

Regulatory Landscape — Metoprolol

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Metoprolol

Supply Chain Risk Assessment — Metoprolol

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Metoprolol Trade Intelligence

Frequently Asked Questions — Metoprolol Exports from India

Who are the top metoprolol exporters from India?

What is the total export value of metoprolol from India?

Which countries import metoprolol from India?

What is the HS code for metoprolol exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of metoprolol exports from India?

Which ports handle metoprolol exports from India?

Why is India a leading exporter of metoprolol?

What certifications do Indian metoprolol exporters need?

How many buyers import metoprolol from India?

What is the market share of the top metoprolol exporter from India?

Analysis Methodology